Literature DB >> 23106572

Metabolic perturbance in autism spectrum disorders: a metabolomics study.

Xue Ming1, T Peter Stein, Virginia Barnes, Nelson Rhodes, Lining Guo.   

Abstract

Autism spectrum disorders (ASD) are a group of biological disorders with associated metabolic derangement. This study aimed to identify a pattern of metabolic perturbance in ASD using metabolomics in urinary specimens from 48 children with ASD and 53 age matched controls. Using a combination of liquid- and gas-chromatography-based mass spectrometry, we detected the levels of 82 metabolites (53 of which were increased) that were significantly altered between the ASD and the control groups using osmolality normalized data. Pattern analysis showed that the levels of several amino acids such as glycine, serine, threonine, alanine, histidine, glutamyl amino acids and the organic acid, taurine were significantly (p≤0.05) lower in ASD children. The levels of antioxidants such as carnosine were also reduced in ASD (p=0.054). Furthermore, several gut bacterial metabolites were significantly altered in ASD children who had gastrointestinal dysfunction. Overall, this study detected abnormal amino acid metabolism, increased oxidative stress, and altered gut microbiomes in ASD. The relationship of altered gut microbial co-metabolism and the disrupted metabolisms requires further investigation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23106572     DOI: 10.1021/pr300910n

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  72 in total

Review 1.  Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.

Authors:  Shivani Ghaisas; Joshua Maher; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2015-11-26       Impact factor: 12.310

2.  The Brain-Gut-Microbiome Axis: What Role Does It Play in Autism Spectrum Disorder?

Authors:  Ruth Ann Luna; Tor C Savidge; Kent C Williams
Journal:  Curr Dev Disord Rep       Date:  2016-02-26

3.  Bisphenol A Exposure in Children With Autism Spectrum Disorders.

Authors:  T Peter Stein; Margaret D Schluter; Robert A Steer; Lining Guo; Xue Ming
Journal:  Autism Res       Date:  2015-01-13       Impact factor: 5.216

Review 4.  Evolution in the Understanding of Autism Spectrum Disorder: Historical Perspective.

Authors:  Mark Mintz
Journal:  Indian J Pediatr       Date:  2016-04-07       Impact factor: 1.967

Review 5.  Effect of L-Carnosine in children with autism spectrum disorders: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Debi Ann Abraham; Krishna Undela; Udayakumar Narasimhan; M G Rajanandh
Journal:  Amino Acids       Date:  2021-03-11       Impact factor: 3.520

Review 6.  The Role of Lipidomics in Autism Spectrum Disorder.

Authors:  Afaf El-Ansary; Salvatore Chirumbolo; Ramesa Shafi Bhat; Maryam Dadar; Eiman M Ibrahim; Geir Bjørklund
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

7.  A Subset of Patients With Autism Spectrum Disorders Show a Distinctive Metabolic Profile by Dried Blood Spot Analyses.

Authors:  Rita Barone; Salvatore Alaimo; Marianna Messina; Alfredo Pulvirenti; Jean Bastin; Alfredo Ferro; Richard E Frye; Renata Rizzo
Journal:  Front Psychiatry       Date:  2018-12-07       Impact factor: 4.157

Review 8.  The gut microbiota-brain axis in behaviour and brain disorders.

Authors:  Livia H Morais; Henry L Schreiber; Sarkis K Mazmanian
Journal:  Nat Rev Microbiol       Date:  2020-10-22       Impact factor: 60.633

9.  Potential serum biomarkers from a metabolomics study of autism.

Authors:  Han Wang; Shuang Liang; Maoqing Wang; Jingquan Gao; Caihong Sun; Jia Wang; Wei Xia; Shiying Wu; Susan J Sumner; Fengyu Zhang; Changhao Sun; Lijie Wu
Journal:  J Psychiatry Neurosci       Date:  2016-01       Impact factor: 6.186

10.  In the search for reliable biomarkers for the early diagnosis of autism spectrum disorder: the role of vitamin D.

Authors:  Afaf El-Ansary; John J Cannell; Geir Bjørklund; Ramesa Shafi Bhat; Abeer M Al Dbass; Hanan A Alfawaz; Salvatore Chirumbolo; Laila Al-Ayadhi
Journal:  Metab Brain Dis       Date:  2018-03-01       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.